Harrow Health drops as quarterly loss widens
** Shares of eye-care company Harrow Health Inc HROW.O
fall ~19% to $22.01 in early trade
** Co reports Q1 net loss of $6.6 mln, compared with a loss
of $2.4 mln a year earlier
** HROW reiterates its annual net revenue forecast of $135
mln to $143 mln
** Shares up ~49% so far this year
(Reporting by Raghav Mahobe)
((Raghav.Mahobe@thomsonreuters.com;))
Recent news on Harrow
See all newsHarrow, Inc. reports results for the quarter ended June 30 - Earnings Summary
Harrow Q2 revenue slightly beats estimates
Viatris raises annual profit forecast on branded drug strength
Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare
Harrow Q1 revenue misses analyst estimates